Please assess the completion status of the following clinical trial:

Trial Title: Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Overweight or obese subjects with BMI \> 30 kg/m2 with type 2 diabetes mellitus taking DPP4 inhibitors alone or in combination with metformin.~2. Women of childbearing potential will have a negative pregnancy test before initiation of medication and within 48 hours of receiving radioisotope.~Exclusion criteria:~1. Structural of metabolic diseases/conditions that affect the gastrointestinal system, or functional gastrointestinal disorders.~2. Irritable bowel syndrome~3. Bristol stool type classification 4-7 per Bowel Disease questionnaire.~4. Subjects with other treatment for type 2 diabetes mellitus.~5. Subjects with HbA1c \> 8%~6. Females who are pregnant or breastfeeding~7. Concomitant use of appetite suppressants, orlistat, phentermine-topiramate ER or lorcaserin.~8. Subjects who are not currently on treatment for cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, neurological, endocrine (other than type 2 diabetes mellitus), and unstable psychiatric disease.~9. Subjects who have donated blood or plasma in the past 8 weeks.~10. Subjects who have participated in another study within the past 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Ox bile extract (Type: ACTIVE_COMPARATOR): Ox bile extract 500 mg tablets taken orally twice daily for 28 (+/- 4) days Gastric Emptying test, Waist and hip measurements, Mixed oral glucose tolerance test, Blood tests
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo tablets taken orally twice daily for 28 (+/- 4) days Gastric Emptying test, Waist and hip measurements, Mixed oral glucose tolerance test, Blood tests

Based on this trial design, predict the completion outcome and termination type (if applicable).